Dosimetry for californium-252 (252Cf) neutron-emitting brachytherapy sources and encapsulation, storage, and clinical delivery thereof
AssigneeNew England Medical Center Hospitals, Inc.
InventorMark J. Rivard
Life of this patent
Estimating the term…
Loading patent…
AssigneeNew England Medical Center Hospitals, Inc.
InventorMark J. Rivard
Estimating the term…
The present invention discloses a methodology for the characterization and determination of mixed-field dosimetry for 252Cf Applicator Tube (AT)-type medical sources, utilizing ionization chambers, GM counters, and Monte Carlo methods. Unlike the previous methodologies, the present invention discloses a specification of dose to muscle, rather than dose to water, for clinical dosimetry of 252Cf medical sources. A dosimetry protocol, similar to that utilized for ICRU-45, with parameters determined specifically for 252Cf brachytherapy is disclosed. Neutron isodose distributions and data necessary for clinical implementation of 252Cf AT sources are also disclosed herein. Additionally, novel methods for the encapsulation, storage, and delivery/implantation of 252Cf radionuclide sources are disclosed.
A device for the encapsulation of radionuclides for use in brachytherapy, comprising:
An encapsulated radionuclide source, for use in a method of brachytherapy treatment comprising administration of the encapsulated radionuclide source to an individual in need thereof, comprising:
A device for encapsulation of radionuclides for use in brachytherapy, the device comprising:
A device for encapsulation of radionuclides for use in brachytherapy, the device comprising:
Dependencies are inferred from the claim text.